Document is current
Any future updates will be listed below
-
Authors
Selberg, Lorenz
Stadtherr, Peter
Dietrich, Sascha
Tran, T. Hien
Luft, Thomas
Hegenbart, Ute https://orcid.org/0000-0003-1917-6746
Bondong, Andrea
Meissner, Julia
Liebers, Nora
Schmitt, Michael https://orcid.org/0000-0002-1579-1509
Ho, Anthony Dick https://orcid.org/0000-0002-1656-0833
Müller-Tidow, Carsten
Dreger, Peter https://orcid.org/0000-0002-7429-8570
- License Information
-
More Information
Article History
Received: 23 April 2020
Accepted: 9 June 2020
First Online: 18 June 2020
Compliance with ethical standards
:
: PD: consultancy for AbbVie, AstraZeneca, Gilead, Janssen, Novartis, Riemser, Roche; speakers bureau for AbbVie, Gilead, Novartis, Riemser, Roche; research support from Neovii and Riemser. MS: research grants from Apogenix, Hexal and Novartis. Travel grants from Hexal and Kite. Financial support for educational activities and conferences from bluebird bio, Kite, and Novartis. Advisory board member of MSD. (Co-)PI of clinical trials of MSD, GSK, Kite, and BMS. Co-Founder and shareholder of TolerogenixX Ltd. LS, PS, SD, THT, TL, UH, JM, AB, NL, ADH, CMT: none.
